Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Q3 and nine months report January – September 2021

Well-positioned to invest following successful EUR 50m tap issueHighlights third quarter 2021 · Gross collections amounted to EUR 12.7m (65.2)* · Net collections amounted to EUR 9.0m (63.1)* · Cash EBITDA amounted to EUR 6.6m (59.3)* · Net loss for the period of EUR 3.2 (profit of 5.2)* · Cash at the end of September 2021 was EUR 98.1m (31.4 at December 2020) · Gross ERC at the end of September 2021 was EUR 235m (258 at December 2020) · EUR 50m of senior secured bonds were issued in September in a tap issue under the EUR 300m bond framework at a price of 102% of the

Q3 and nine months report January – September 2021

Well-positioned to invest following successful EUR 50m tap issueHighlights third quarter 2021 · Gross collections amounted to EUR 11.5m (64.2)* · Net collections amounted to EUR 8.7m (62.1)* · Cash EBITDA amounted to EUR 6.9m (58.6)* · Net loss for the period of EUR 2.3m (profit of 5.1)* · Cash at the end of September 2021 was EUR 96.7m (30.7 at December 2020) · EUR 50m of senior secured bonds were issued in September in a tap issue under the EUR 300m bond framework at a price of 102% of the nominal amount, to fund future acquisitions of portfolios Highlights nine

BONESUPPORT Holding AB (publ) – Publishes Q3 2021 Interim report

Lund, Sweden, 08:00 CEST, November 4, 2021 – BONESUPPORT Holding AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today publishes the interim report for the third quarter 2021. BEST SALES QUARTER TO DATE JULY – SEPTEMBER 2021 · Net sales increased by 14 percent (26 percent at constant exchange rates) and amounted to SEK 54.9 million (48.1). · The North America (NA) segment reported a sales increase of 16 percent (34 percent at constant exchange rate). · The Europe & Rest of the World (EUROW) segment reported a sales increase of 12 percent

Interim report July - September 2021

Gothenburg, November 4, 2021 - Vicore Pharma Holding AB (publ) publishes the interim report for the third quarter 2021.Important events during the third quarter · In August, Vicore announced a strenghtened management team with three senior recruitments; Jessica Shull, Head of Digital Therapeutics, Åsa Magnusson, Chief Commercial Officer and Mikael Nygård, VP Business Development. · In September, Vicore announced that the first patients in the global phase 3 trial with C21 in COVID-19 (ATTRACT-3) were dosed. · In September, Vicore announced that the company was granted a patent in

SaltX Technology Holding AB Interim report 3 2021

FINANCIAL EVENTS Third quarter · Net sales amounted to MSEK 0.1 (0.0) · Operating profit/loss (EBIT) totaled MSEK -8.0 (-8.0) · Cash flow from operating activities amounted to MSEK -3.7 (-6.6) · Earnings per share before and after dilution amounted to SEK -0.05 (-0.11) Year to date January - September · Net sales amounted to MSEK 0.2 (0.1) · Operating profit/loss (EBIT) totaled MSEK -24.0 (-25.3) · Cash flow from operating activities amounted to MSEK -21.8 (-25.8) · Earnings per share before and after dilution amounted to SEK -0.24 (-0.32) SIGNIFICANT

SBB, Interim Report January – September 2021: Profit after tax SEK 8.56 per class A and B ordinary share

SAMHÄLLSBYGGNADSBOLAGET I NORDEN AB (PUBL): INTERIM REPORT JANUARY – SEPTEMBER 2021 IN BRIEF · Rental income increased to SEK 4,235m (3,868). · The operating surplus increased to SEK 2,965m (2,669). · Cashflow from operating activities before changes in working capital was SEK 1,721m (1,590). · Profit before tax increased to SEK 15,746m (6,142), of which: · Profit from property management is included in the amount of SEK 2,437m (1,601). The profit from property management includes costs for early repayment of loans and other non-recurring costs of SEK -324m (-309). ·

Navamedic ASA: Q3 2021 financial results

Oslo, 4 November 2021 – Navamedic ASA (OSE: NAVA) grew revenues by 12% in the third quarter of 2021 compared to the same quarter last year. The company reported revenues of NOK 63.6 million in the third quarter of 2021 with an EBITDA of NOK 3.7 million, driven by underlying growth in the portfolio and Mysimba® in particular. The company reiterates its mid-term ambition of building a NOK 500 million company through organic growth.“Our portfolio of specialty pharma and consumer health products continue to grow with particularly strong performance for the obesity medicine Mysimba, which grew

Relais Group Plc Interim Management Statement January 1–September 30, 2021 (unaudited) – The profitable growth continues

Relais Group PlcCompany release 4 November 2021, 9:00 a.m. EET This release is a summary of Relais Group's Interim Management Statement January-September 2021. The full release is attached to this company release and is available on our website at https://relais.fi/en/investors/.  JULY–SEPTEMBER 2021 IN BRIEF · Net sales totaled EUR 58.6 million (July – September 2020: 32.8), +78.6% change · EBITDA was EUR 8.7 (5.6) million, 14.8% (16.9%) of net sales, +56.4% change · EBITA was EUR 8.3 (5.5) million, 14.2% (16.6%) of net sales, +52.8% change · EBIT was EUR 5.0 (3.6)

Karnov Group reports third quarter results 2021

Another growth quarterFINANCIAL HIGHLIGHTS third QUARTER · Net sales increased by 15% to SEK 222 m (193), organic growth was 8%. · EBITA amounted to SEK 80 m (77) with EBITA margin of 36.1% (39.9%). · Adjusted EBITA amounted to SEK 88 m (77) with EBITA margin of 39.5% (39.9%). · Net result amounted to SEK 23 m (28). · Earnings per share after dilution amounted to SEK 0.24 (0.28). · Adjusted operating cash flow amounted to SEK -4 m (-1). CEO Pontus bodelsson comments on the quarter: We deliver strong results in the third quarter, both on top-line and margins, and at

Polygiene AB (publ.) Interim Report July 1 – September 30, 2021

New sales record and strong overall key figuresQ3 in brief (July - September 2021) · Net sales amounted to MSEK 52.3 (22.9), a positive growth by 129 % · The operating EBIT amounted to MSEK 15.7 (2.4), an increase by 554 % · The gross margin amounted to 64.3 (70.4) % · Cash flow amounted to MSEK 8.4 (0.5) Events during the quarter (July - September 2021) · Global Golf Safety improve hygiene on the golf course with Biomaster technology · Ammique beds, designed with hygiene as a priority, with components featuring Biomaster protection, now supports Terra Carta ·

Hemnet Group Interim report Q3 2021

Strong growth in net sales and adjusted EBITDA Summary for the period July-September 2021 · Net sales increased 38.0 percent to SEK 195.8m (141.9) · Adjusted EBITDA increased 61.6 percent to SEK 102.3m (63.3) · Operating profit increased 93.7 percent to SEK 82.7m (42.7) · Continued growth in number of published listings, that increased 5.3 percent compared to last year · ARPL, average revenue per listing, increased 53.7 percent to SEK 2,642 (1,719)   Summary for the period January-September 2021 · Net sales increased 37.2 percent to SEK 550.8m (401.4) ·

Optomed Plc: Interim report, January – September 2021

Optomed Plc Stock Exchange Release 4 November 2021 at 9:00, Helsinki Optomed Plc: Interim report, January – September 2021 July – September 2021 · Group revenue was steady and amounted to  EUR 3,342 (3,338) thousand · Devices segment revenue decreased by 24.1 percent to EUR 1,167 (1,537) thousand, as no camera deliveries were  made to China after the large inventory deliveries in the first half of the year. Sales to North America and Europe continued strong growth, as well as sales to OEM customers · The Software segment revenue increased, by 20.8 percent to EUR 2,176 (1,

Outokumpu interim report January–September 2021: Realized prices for stainless steel increased and Q3 adjusted EBITDA rose to EUR 295 million

Outokumpu OyjInterim reportNovember 4, 2021 at 9.00 am EETOutokumpu interim report January–September 2021: Realized prices for stainless steel increased and Q3 adjusted EBITDA rose to EUR 295 million  Highlights in Q3 2021 · Stainless steel deliveries were 575,000 tonnes (488,000 tonnes)[1]. · Adjusted EBITDA increased to EUR 295 million (EUR 22 million). · EBITDA was EUR 295 million (EUR 10 million). · Operating cash flow amounted to EUR 180 million (EUR 170 million). · Net debt decreased to EUR 749 million (June 30, 2021: EUR 897 million). · Gearing decreased to

Konecranes and Cargotec announce planned high-level operating model and leadership team for the Future Company

KONECRANES PLC STOCK EXCHANGE RELEASE November 4, 2021 09:00 AM EET Konecranes and Cargotec announce planned high-level operating model and leadership team for the Future Company As announced earlier, Konecranes and Cargotec will merge to create a global leader in sustainable material flow. The merger is expected to take place by the end of H1/2022, and Konecranes and Cargotec today announce the planned high-level operating model and leadership team of the Future Company. “The planned high-level operating model of the Future Company is the result of months of integration planning

Outokumpu – Voluntary total redemption of rated senior secured fixed rate notes due in 2024

Outokumpu OyjInsider informationNovember 4, 2021 at 8.57 am EETOutokumpu – Voluntary total redemption of rated senior secured fixed rate notes due in 2024 Outokumpu Oyj announces that it will redeem in full its outstanding 4.125 percent rated senior secured fixed rate notes due in 2024 (ISIN FI4000331004, OUTJ412524) on the redemption date of December 7, 2021 in accordance with section 8.4 of the terms and conditions of the notes. The notes are listed on the official list of Nasdaq Helsinki Ltd. The current outstanding nominal amount of the notes is EUR 250 million. On the

Outokumpu increases its financial target on EBITDA run-rate improvement

Outokumpu OyjStock exchange releaseNovember 4, 2021 at 8.55 am EETOutokumpu increases its financial target on EBITDA run-rate improvement Outokumpu launched a new strategy in November 2020 and set financial targets by the end of 2022. The targets included an EBITDA run-rate improvement by EUR 200 million and a reduction of the net debt to EBITDA ratio to below 3.0. The company has made strong progress in its strategy execution. With a commitment to continue de-risking the company by the end of 2022, Outokumpu increases its initial EBITDA run-rate improvement target from EUR 200

Invitation to the presentation of Elekta’s second quarter 2021/22

SWEDEN, November 4, 2021 – Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at 10:00 a.m. CET on November 25. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day. The company’s development will be presented by Elekta’s President and CEO, Gustaf Salford, together with CFO, Johan Adebäck. After the presentation, held in English, a Q&A session will follow. The presentation will be broadcast live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording

HKScan’s EBIT stable, profit improvement continued in Finland and Sweden

HKScan Corporation, January-September Interim Report, 4 November 2021 at 8.30 a.m. Finnish timeHKScan’s Interim Report 1 January – 30 September 2021  HKScan’s EBIT stable, profit improvement continued in Finland and Sweden July-September 2021 · HKScan’s net sales totalled EUR 446.8 (438.3) million. Clear growth in retail sales of own branded products continued. Sales clearly increased particularly in the product categories with higher added value, such as meals and meal components. Food service sales increased as a result of the gradual removal of restrictions related to the

GARO will publish its report for the third quarter 2021 at 08.30 CEST on Thursday, November 11.

GARO will publish its report for the third quarter 2021 at 08.30 CEST on Thursday, November 11. Conference call at 09.30 CESTThe company will host a conference call for the financial community at 09.30 CEST the same day. The conference will be hosted by Patrik Andersson, President & CEO and Helena Claesson, Chief Financial Officer. Dial in numbers:Sweden: 010 884 8016All other locations: +44 20 3936 2999Participant Access Code: 45 59 87  The presentation material will be published at www.garo.se prior to the conference call. The conference will also be audio webcasted in “

Kid ASA - Third Quarter 2021 Results

Lier, 4 November 2021: The board of Directors of Kid ASA has approved the financial report for the third quarter of 2021.Q3 2021 was the 6th consecutive quarter with year-on-year increased Earnings Per Share for the Kid Group with high profitability, driven by continued revenue growth, maintained gross margins and stringent cost control. Key financial highlights · Revenues increased by 3.6% and like-for-like growth increased by 0.1%. Compared to Q3 2019, like-for-like sales increased by +17.4% · Gross margin decreased by 1.7 percentage points to 61.4%, driven by increased B2B

Storskogen acquires Special Wheels

Storskogen has entered into an agreement to acquire Specialfälgar i Kungsbacka Holding AB (Special Wheels). Special Wheels is a wheel supplier in the Nordics for passenger cars and commercial vehicles. The company reported a turnover of 317 MSEK in 2020 and reports continued strong growth in 2021 with high profitability. Storskogen expects to complete the acquisition in the beginning of December 2021.Special Wheels is a designer and supplier of wheels and accessories to passenger cars and commercial vehicles, mainly through the proprietary brands Nitro Wheels and Image Wheels. The company

Save the Date: Nordic Nanovector ASA to host in-person and virtual R&D Day on 30 November 2021

Oslo, Norway, 4 November 2021 Nordic Nanovector ASA (OSE: NANOV), a clinical stage biotechnology company developing targeted radiopharmaceuticals to extend and improve the lives of patients with haematological cancers, will host an R&D Day on Tuesday, 30 November 2021 at 14:00 CET/ 13:00 GMT/ 08:00 ET. The meeting will be held in person in Oslo and will also be available via live webcast. The meeting, intended for investors and analysts, will provide an overview of the Company’s vision, progress to date, development pipeline and corporate strategy. Presentations will be delivered

Teleste 1-9/2021: Adjusted operating result on par with the reference period, net sales decreased, component availability restricted deliveries, strong growth in orders received.

TELESTE CORPORATION         INTERIM REPORT 4 NOVEMBER 2021 AT 8:30 EET TELESTE CORPORATION INTERIM REPORT 1 JANUARY TO 30 SEPTEMBER 2021 ADJUSTED OPERATING RESULT ON PAR WITH THE REFERENCE PERIOD, NET SALES DECREASED, COMPONENT AVAILABILITY RESTRICTED DELIVERIES, STRONG GROWTH IN ORDERS RECEIVED July-September 2021 - Net sales amounted to EUR 32.3 (35.7) million, a decrease of 9.5%- Adjusted operating result was EUR 2.3 (2.2) million, an increase of 2.6%- Operating result amounted to EUR 2.3 (2.2) million, an increase of 2.6%- Earnings per share, including discontinued

There are no items matching the current filter
There are no more items matching the current filter
Back to top